Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.
Phyllis Walsh
Advertisement
Phyllis Walsh is associate director of Merck and Company, Inc.
Articles by Phyllis Walsh
Advertisement
Latest Updated Articles
Third-Party Audits: Ensuring That Excipients Meet cGMP RequirementsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Standardizing Operations to Meet Global Sustainability and Resilience Goals
2
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
3
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
4
PharmTech Weekly News Roundup — Week of October 27, 2025
5
